Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-24

Clinical Trial Update: Topical Cannabidiol Lotion for Pruritus Relief in Scleroderma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating topical cannabidiol lotion for pruritus relief in systemic sclerosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical cannabidiol lotion (cannabidiol)

Snippet

Sponsor: Khon Kaen University | Conditions: Mediciine, Systemic Sclerosis (SSc) | Phase 3 | Status: RECRUITING